We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,446 results
  1. Bupivacaine

    Reference work entry 2024
  2. Freeze-drying of bupivacaine lipospheres: preparation, characterization, and evaluation of anti-microbial properties

    Purpose

    To prepare freeze-dried bupivacaine lipospheres intended for topical application in burn injuries. The aim was improving the storage stability...

    Sepehr Labanian, Homa Faghihi, ... Aliakbar Jafarian in DARU Journal of Pharmaceutical Sciences
    Article 29 February 2024
  3. Development of an Accelerated Rotator-based Drug Release Method for the Evaluation of Bupivacaine Multivesicular Liposomes

    Purpose

    A multivesicular liposome (MVL) is a liposomal vehicle designed to achieve sustained release characteristics for drugs with short half-lives....

    Ziyun **a, Minzhi Yu, ... Anna Schwendeman in Pharmaceutical Research
    Article 11 January 2024
  4. Comparative study of iontophoresis-assisted transdermal delivery of bupivacaine and lidocaine as anesthetic drugs

    Postoperative pain management is an important aspect of the overall surgical care process. Effective pain management not only provides patient...

    Rawita Morarad, Ketchada Uerpairojkit, ... Anuvat Sirivat in Drug Delivery and Translational Research
    Article 23 May 2024
  5. Antinociceptive effects of bupivacaine and its sulfobutylether-β-cyclodextrin inclusion complex in orofacial pain

    Bupivacaine hydrochloride (BVC) represents an option to produce long-lasting analgesia, and complexation in cyclodextrins has shown improvements in...

    Juliana Souza de Freitas Domingues, Silmara Martins Dias dos Santos, ... Luiz Eduardo Nunes Ferreira in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 01 August 2022
  6. Effect of bupivacaine intraperitoneal and intra-abdominal bicarbonate in reducing postoperative pain in laparoscopic cholecystectomy: a double-blind randomized clinical trial study

    Objective

    We aimed to compare the effect of bupivacaine intraperitoneal with intra-abdominal bicarbonate in reducing postoperative pain in...

    Nasim Nikoubakht, Seyed Hamid Reza Faiz, ... Leila Borhani Zonoz in BMC Research Notes
    Article Open access 03 June 2022
  7. Bupivacaine Induces ROS-Dependent Autophagic Damage in DRG Neurons via TUG1/mTOR in a High-Glucose Environment

    Bupivacaine (BP) is a commonly clinically used local anesthetic (LA). Current studies suggest that neurological complications are increased in...

    Luying Lai, Yongwei Wang, ... Shiyuan Xu in Neurotoxicity Research
    Article 18 January 2022
  8. Bupivacaine inhibits a small conductance calcium‐activated potassium type 2 channel in human embryonic kidney 293 cells

    Background

    Bupivacaine blocks many ion channels in the heart muscle, causing severe cardiotoxicity. Small-conductance calcium-activated potassium type...

    Hongfei Chen, Zhousheng **, ... Zhijian Fu in BMC Pharmacology and Toxicology
    Article Open access 12 March 2021
  9. LncRNA OIP5-AS1 Mitigates Bupivacaine-Induced Neurotoxicity in Dorsal Root Ganglion Neurons Through Regulating NFAT5 Expression via Sponging miR-34b

    Bupivacaine (BUP), which is widely used in anesthesia, can cause neurotoxicity and neurological abnormalities. This work intended to study the...

    Yina Yin, Min Ma, ... Keliang Zhang in Neurotoxicity Research
    Article 08 September 2022
  10. Porous Core/Dense Shell PLA Microspheres Embedded with High Drug Loading of Bupivacaine Crystals for Injectable Prolonged Release

    Objective of the study was to design an injectable microsphere preparation with high drug loading of bupivacaine for prolonged release and local...

    **ghua Xu, Yanjie Bai, ... Hui Xu in AAPS PharmSciTech
    Article 06 January 2021
  11. MiRNA-494-3p Regulates Bupivacaine-Induced Neurotoxicity by the CDK6-PI3K/AKT Signaling

    Bupivacaine (BUP) is a long-acting amide local anesthetic that may induce strong neurotoxicity and neurological complications. In this study, we...

    Licheng Zhang, Lifeng Zhang, Fengying Guo in Neurotoxicity Research
    Article 15 October 2021
  12. Dexmedetomidine suppresses bupivacaine-induced parthanatos in human SH-SY5Y cells via the miR-7-5p/PARP1 axis-mediated ROS

    This study aims to explore the regulatory mechanisms of dexmedetomidine in parthanatos. MTT assay was applied to reveal cell viability; JC-1 staining...

    Ting Zheng, Chunying Zheng, ... **aochun Zheng in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 28 September 2020
  13. Knockdown of lincRNA PADNA promotes bupivacaine-induced neurotoxicity by miR-194/FBXW7 axis

    Background

    The aim of the study was to explore the function and mechanism of lincRNA PADNA in bupivacaine-induced neurotoxicity.

    Methods ...
    Fan Yuning, Chen Liang, ... Gong Shengkai in Molecular Medicine
    Article Open access 13 August 2020
  14. A comparison of bupivacaine lavage and diclofenac suppository effects on post-operative pain of laparascopic transabdominal pre-peritoneal herniorrhaphy: a randomized clinical trial study

    Objectives

    Injection of a topical anaesthetic has been proved to be helpful with reducing pain after laparoscopic herniorrhaphy. We aimed to assess...

    Alireza Negahi, Seyed Hamzeh Mousavi, ... Fatemeh Jahanshahi in BMC Research Notes
    Article Open access 01 October 2020
  15. Effect of Active Pharmaceutical Ingredient, Lipid Composition, and Thermal Processing on the Physical Stability of Local Anesthetic-loaded Lipid Microparticles

    Purpose

    This study investigates the effects of heat annealing, drug, and lipid composition on the physical stability of solid lipid microparticles...

    Sierra Erickson, Jonathan Vizmeg, ... Brett Davis in Journal of Pharmaceutical Innovation
    Article 15 May 2023
  16. Dexmedetomidine enhances tolerance to bupivacaine cardiotoxicity in the isolated rat hearts: alpha 2 adrenoceptors were not involved

    Background

    Dexmedetomidine was proved to mitigate bupivacaine-induced cardiotoxicity but mechanism of this ability is still unclear. This study was...

    Fangfang **a, Zhousheng **, ... Hongfei Chen in BMC Pharmacology and Toxicology
    Article Open access 21 November 2019
  17. Bupivacaine-Induced Neurotoxicity Is Modulated by Epigenetic Axis of Long Noncoding RNA SNHG16 and Hsa-miR-132-3p

    Clinical application of local anesthetic reagent, liposomal bupivacaine (BUP), may cause irreversible damage to human nerve system. In this study, we...

    Lei Guan, Tianzuo Li, **gwen Jiang in Neurotoxicity Research
    Article 25 April 2020
  18. Are local analgesics effective in reducing autonomic dysreflexia in individuals with spinal cord injury? A systematic review

    Study design

    Systematic review.

    Objectives

    To systematically review the evidence on the use of local analgesics, specifically lidocaine or...

    Katherine Gray, Whitley Sheehan, ... Andrei V. Krassioukov in Spinal Cord
    Article 12 August 2022
Did you find what you were looking for? Share feedback.